349 related articles for article (PubMed ID: 38672496)
1. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.
Wang S; Gu S; Chen J; Yuan Z; Liang P; Cui H
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672496
[TBL] [Abstract][Full Text] [Related]
2. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
[TBL] [Abstract][Full Text] [Related]
3. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
Kristoffersen K; Villingshøj M; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2013 Jul; 14(7):625-37. PubMed ID: 23792644
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Gersey Z; Osiason AD; Bloom L; Shah S; Thompson JW; Bregy A; Agarwal N; Komotar RJ
World Neurosurg; 2019 Nov; 131():252-263.e2. PubMed ID: 31376551
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
6. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
Jin J; Grigore F; Chen CC; Li M
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Notch signaling activation to human glioblastoma multiforme.
Kanamori M; Kawaguchi T; Nigro JM; Feuerstein BG; Berger MS; Miele L; Pieper RO
J Neurosurg; 2007 Mar; 106(3):417-27. PubMed ID: 17367064
[TBL] [Abstract][Full Text] [Related]
9. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
10. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.
El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y
Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764
[TBL] [Abstract][Full Text] [Related]
11. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
12. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
[TBL] [Abstract][Full Text] [Related]
15. NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.
Yahyanejad S; King H; Iglesias VS; Granton PV; Barbeau LM; van Hoof SJ; Groot AJ; Habets R; Prickaerts J; Chalmers AJ; Eekers DB; Theys J; Short SC; Verhaegen F; Vooijs M
Oncotarget; 2016 Jul; 7(27):41251-41264. PubMed ID: 27183910
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling in glioblastoma: a developmental drug target?
Lino MM; Merlo A; Boulay JL
BMC Med; 2010 Nov; 8():72. PubMed ID: 21078177
[TBL] [Abstract][Full Text] [Related]
17. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
[TBL] [Abstract][Full Text] [Related]
18. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
Li Q; Wang J; Ma X; Wang M; Zhou L
J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
[TBL] [Abstract][Full Text] [Related]
19. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
Xu Y; Stamenkovic I; Yu Q
Cancer Res; 2010 Mar; 70(6):2455-64. PubMed ID: 20197461
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
Hovinga KE; Shimizu F; Wang R; Panagiotakos G; Van Der Heijden M; Moayedpardazi H; Correia AS; Soulet D; Major T; Menon J; Tabar V
Stem Cells; 2010 Jun; 28(6):1019-29. PubMed ID: 20506127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
